JPMorgan Chase increases its stake in ALI HEALTH (00241) by approximately 172 million shares at a price of HK$6.069 per share.
After the increase, the latest number of shares held is about 1.688 billion, and the latest shareholding ratio is 10.43%.
The latest data from the Hong Kong Stock Exchange shows that on November 26, JPMorgan Chase increased its holdings of ALI HEALTH (00241) by approximately 171,589,632 shares, at a price of 6.069 Hong Kong dollars per share, with a total amount of approximately 1.041 billion Hong Kong dollars. After the increase, the latest number of shares held is approximately 1.688 billion shares, with a latest holding percentage of 10.43%.
Related Articles
Jiangsu Hengrui Pharmaceuticals (01276): As of the end of November, it has repurchased a total of 8.89 million A shares.
Lemax Technology (02539): Hong Kong public offering was oversubscribed 7324.29 times. The issue price is HK$40 per share.
C-MER MEDICAL (03309) spent 280,100 Hong Kong dollars on repurchasing 160,000 shares on December 2nd.
Jiangsu Hengrui Pharmaceuticals (01276): As of the end of November, it has repurchased a total of 8.89 million A shares.
Lemax Technology (02539): Hong Kong public offering was oversubscribed 7324.29 times. The issue price is HK$40 per share.
C-MER MEDICAL (03309) spent 280,100 Hong Kong dollars on repurchasing 160,000 shares on December 2nd.
